SCHEMBL5886582

SCHEMBL5886582

CCCCC#Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.52
CYP1A1 P04798 1/20 0.52
CYP1B1 Q16678 1/20 0.52
FFAR1 O14842 2/20 0.48
FFAR4 Q5NUL3 2/20 0.48
MMP2 P08253 1/20 0.47
MMP12 P39900 1/20 0.47
TNK2 Q07912 1/20 0.46
CHRNA7 P36544 3/20 0.45
CHRNA10 Q9GZZ6 3/20 0.45
CHRNA9 Q9UGM1 3/20 0.45
KCNH2 Q12809 2/20 0.43
NPSR1 Q6W5P4 1/20 0.41
MAPT P10636 3/20 0.40
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL614578 0.88 CYP1A2 (0.50) CYP1A2FFAR1FFAR4MMP2MMP12
Hydrochloric Acid SCHEMBL31144511 0.86 BLM (0.52) CYP1A2FFAR1FFAR4MMP2MMP12
SCHEMBL5886588 0.86 FFAR1 (0.53) FFAR1FFAR4MMP2MMP12TNK2
SCHEMBL5089564 0.85 NPSR1 (0.47) CYP1A2FFAR1FFAR4MMP2MMP12
SCHEMBL8846653 0.84 FFAR1 (0.51) FFAR1FFAR4MMP2MMP12TNK2
SCHEMBL3062128 0.84 FFAR1 (0.47) FFAR1FFAR4MMP2MMP12TNK2
SCHEMBL9249328 0.84 FFAR1 (0.43) FFAR1FFAR4MMP2MMP12TNK2
SCHEMBL20152456 0.84 TSHR (0.56) FFAR1FFAR4MMP2MMP12TNK2
SCHEMBL9247329 0.84 KCNH2 (0.51) FFAR1FFAR4MMP2MMP12TNK2
SCHEMBL5314931 0.82 FFAR1 (0.55) CYP1A2FFAR1FFAR4MMP2MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7105707-B2 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds PHARMACORE, INC. (US) 2006-09-12 US disclosed
US-20050137402-A1 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds DSM N.V. (NL) 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137402-A1 Process for preparing alkynyl-substituted aromatic and heterocyclic compounds NAT1, B3GNT2, NISCH CYP1A2 481/4885CYP1A1 301/4885CYP1B1 483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.